I have a family history of pancreatic cancer. Should I be screened?

Having cases of pancreatic cancer in the family can increase the risk of the disease. However, not everyone with an affected family member needs to undergo periodic examinations. The degree of kinship, the number of affected family members, and hereditary genetic alterations help define who may benefit from screening.

Who is at higher risk with a family history of pancreatic cancer?

The risk primarily depends on the number of affected family members and the degree of kinship. Parents, children, and siblings are considered first-degree relatives. The presence of multiple cases of pancreatic cancer in the same family may indicate a familial predisposition. The risk increases especially when there are two or more affected close relatives. Some individuals also have hereditary genetic alterations that increase the predisposition to pancreatic cancer and other types of cancer. Therefore, knowing which family members had cancer and the age at which they received the diagnosis is important during evaluation.

Does having only one family member with pancreatic cancer mean I need screening?

Having only one family member with pancreatic cancer does not automatically mean there is an indication for periodic screening examinations. For individuals without a known hereditary predisposition, guidelines focus surveillance on those with a more significant family history. The evaluation considers how many family members had the disease and how these individuals are related to each other. Pancreatic cancer screening is also not recommended for the general population without high-risk factors. Therefore, the decision should stem from an individual assessment of family history.

When might a genetic evaluation be indicated?

Genetic evaluation may be important when personal or family history suggests a hereditary cancer predisposition syndrome. Alterations in genes such as BRCA1, BRCA2, PALB2, ATM, and CDKN2A may be related to an increased risk of pancreatic cancer. Lynch syndrome and Peutz-Jeghers syndrome are also associated with an increased risk. The presence of a genetic alteration does not mean that the person will necessarily develop cancer. The result helps estimate the risk and may modify the follow-up strategy. Genetic counseling allows for the analysis of family history and defines when genetic testing is appropriate. Whenever possible, family genetic investigation can begin with the individual who developed cancer.

What tests are used to monitor high-risk individuals?

Abdominal magnetic resonance imaging with magnetic resonance cholangiopancreatography and endoscopic ultrasonography are among the main methods used in the surveillance of high-risk individuals. Magnetic resonance cholangiopancreatography, also known as MRCP, allows for a detailed evaluation of the pancreas and its ducts. Endoscopic ultrasonography uses a device introduced through the digestive tract to obtain high-resolution images of the pancreas. Computed tomography is not usually the primary examination used for periodic surveillance of asymptomatic high-risk individuals. The choice and alternation of examinations may vary according to individual risk and findings identified during follow-up.

At what age should pancreatic cancer screening begin?

The age of onset depends on the cause of the increased risk. In individuals with elevated family risk, different consensuses use approximately 50 years of age or 10 years before the age at which the youngest family member developed pancreatic cancer as a reference. Some hereditary syndromes warrant an earlier start. Individuals with Peutz-Jeghers syndrome and certain alterations in the CDKN2A gene, for example, may begin surveillance before age 50. Therefore, there is no single starting age that is appropriate for all families.

How often are the tests performed?

When surveillance is indicated and no concerning findings are identified, follow-up is usually performed at approximately 12-month intervals. Alterations found in examinations may require evaluations at shorter intervals or additional tests. The frequency depends on the type, size, and characteristics of the alteration found. Surveillance programs should preferably be carried out in centers with experience in monitoring individuals at high risk for pancreatic cancer.

What to do when there is pancreatic cancer in the family?

The first step is to organize the family history. It is important to know which relatives had cancer, what type of tumor it was, and, when possible, the age at diagnosis. This information allows for an assessment of whether genetic counseling is indicated and whether the risk is sufficient to warrant periodic pancreatic examinations. Having pancreatic cancer in the family does not necessarily mean that the disease will be hereditary. Family history evaluation helps identify who only needs to maintain usual care and who may benefit from a specific surveillance strategy.